Medisys offloads safety products to focus on glucose monitoring
This article was originally published in Clinica
Executive Summary
UK company Medisys is to divest its line of medical safety products in order to focus on its core blood glucose monitoring business. The decision comes less than a year after the launch of the Futura safety syringe, which the company had hoped would become a promising revenue driver.